terazosin and Diabetes Mellitus studies

terazosin and Diabetes Mellitus

terazosin has been researched along with Diabetes Mellitus in 2 studies

Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia

Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.

Research Excerpts

Excerpt	Relevance	Reference
"Treatment of benign prostatic hyperplasia (BPH) with nonselective alpha1 antagonists such as terazosin, doxazosin, and prazosin results in blood pressure reduction due to vasodilation."	3.71	Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study. ( Chao, J; Chrischilles, E; Gilden, D; Kreder, KJ; Rubenstein, L; Shah, H, 2001)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

2 (100.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Bozlu, M	1
Ulusoy, E	1
Cayan, S	1
Akbay, E	2
Görür, S	1
Chrischilles, E	1
Rubenstein, L	1
Chao, J	1
Kreder, KJ	1
Gilden, D	1
Shah, H	1

Studies

Bozlu, M

Ulusoy, E

Cayan, S

Akbay, E

Görür, S

Chrischilles, E

Rubenstein, L

Chao, J

Kreder, KJ

Gilden, D

Shah, H

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
The Effects of Systemic Alfuzosin and Tamsulosin Hydrochloride on Choroidal Thickness and Pupil Diameter Sizes in Cases With Benign Prostatic Hyperplasia[NCT03144596]	Phase 4	63 participants (Actual)	Interventional	2015-10-29	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

The Effects of Systemic Alfuzosin and Tamsulosin Hydrochloride on Choroidal Thickness and Pupil Diameter Sizes in Cases With Benign Prostatic Hyperplasia[NCT03144596]

Phase 4

63 participants (Actual)

Interventional

2015-10-29

Completed

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for terazosin and Diabetes Mellitus

Article	Year
A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes. Scandinavian journal of urology and nephrology, 2004, Volume: 38, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus; Doxazosin;	2004
Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study. Clinical therapeutics, 2001, Volume: 23, Issue:5 Topics: Accidental Falls; Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Cohort Studies; Comor	2001

Article

Year

A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes.

Scandinavian journal of urology and nephrology, 2004, Volume: 38, Issue:5

Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus; Doxazosin;

2004

Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort study.

Clinical therapeutics, 2001, Volume: 23, Issue:5

Topics: Accidental Falls; Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Cohort Studies; Comor

2001